TrialHuman vaccines & immunotherapeutics2019

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.

Tetsuo Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.